Targeting mechanotransduction in osteosarcoma
- PMID: 40609212
- DOI: 10.1016/j.bbrc.2025.152272
Targeting mechanotransduction in osteosarcoma
Abstract
Osteosarcoma (OS) is a common primary bone malignancy predominantly affecting adolescents. The bone microenvironment is crucial in modulating the initiation and progression of OS. OS cells transduce mechanical signals into biochemical signals, thereby regulating cellular behavior. A comprehensive examination of the complexities of mechanotransduction in OS strengthens the theoretical framework for understanding its regulatory mechanisms. Existing theoretical frameworks often fail to integrate biomechanical cues with epigenetic regulation, which is essential for a comprehensive understanding of OS pathogenesis. This review highlights the aberrant mechanotransduction in OS cells, contrasting with physiological bone remodeling, examines key signaling molecules involved, and summarizes potential therapeutic strategies targeting mechanotransduction. These insights provide a foundation for developing innovative and targeted therapies for OS.
Keywords: Mechanotransduction; Osteosarcoma; Signaling pathway; Treatment strategy.
Copyright © 2025. Published by Elsevier Inc.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no conflict of interest and consent for publication. This study was funded by Jilin Provincial Department of Science and Technology (Grant No. 20230101163JC). The authors confirm independence from the sponsors. The content of the article has not been influenced by the sponsors.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
